a public good project by the
Synthesis
Company
of California

© 2026

Sharon E. Frey | doi.page

0 works0 citations0 h-index

Sharon E. Frey

UCLouvain Saint-Louis Brussels(BE)

Publications by Year

Research Areas

Influenza Virus Research Studies, Poxvirus research and outbreaks, Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research

Most-Cited Works

→ Clinical Responses to Undiluted and Diluted Smallpox Vaccine(2002)261 cited
→ Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults(2010)248 cited
→ Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues(2010)221 cited
→ Dose-Related Effects of Smallpox Vaccine(2002)182 cited
→ Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles(2011)176 cited
→ Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022(2022)175 cited

→ A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans(2013)

174 cited

→ AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial(2013)162 cited

→ Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults(2010)158 cited

→ Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects(2015)146 cited